Cargando…
Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
BACKGROUND: Botulinum toxin type A (BTX-A) has been reported to have analgesic effects independent of its action on muscle tone, mostly by acting on neurogenic inflammatory mediators and controlling the neurotransmitter release of sensory and autonomic nerve terminals that are involved in many chron...
Autores principales: | Shehata, Hatem S, El-Tamawy, Mohamed S, Shalaby, Nevin M, Ramzy, Gihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177416/ https://www.ncbi.nlm.nih.gov/pubmed/24251833 http://dx.doi.org/10.1186/1129-2377-14-92 |
Ejemplares similares
-
Oromandibular Dystonia in Yemeni Patients with Khat Chewing: A Response to Botulinum Toxin Treatment
por: Shehata, Hatem S., et al.
Publicado: (2014) -
Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia
por: Kayani, Abdul Mueez Alam, et al.
Publicado: (2022) -
Outcome of medical and surgical management in intractable idiopathic trigeminal neuralgia
por: Salama, Hassan, et al.
Publicado: (2009) -
Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
por: Verma, Gaurav
Publicado: (2013) -
Management of Trigeminal Neuralgia with Botulinum Toxin Type A: Report of Two Cases
por: Pearl, Craig, et al.
Publicado: (2022)